Small Business Innovation Research · Small Business Technology Transfer
DFH Pharma, Inc: SBIR & STTR awards
4 awards worth $2.29M to 1 companies since 2013 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
DFH Pharma, Inc's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 0 | 1 | $986.9K |
| 2020 | 0 | 1 | $943.1K |
| 2018 | 1 | 0 | $171.5K |
| 2013 | 1 | 0 | $186.4K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents · topic NIAID | DFH Pharma, Inc · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $986.9K | 2025-09-26 |
| Preclinical Development of 2nd Generation HIV Maturation Inhibitors · topic NIAID | DFH Pharma, Inc · Maryland | Department of Health and Human Services · National Institutes of Health | STTR Phase II | $943.1K | 2020-07-08 |
| Preclinical Development of 2nd Generation HIV Maturation Inhibitors · topic 400 | DFH Pharma, Inc · Maryland | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $171.5K | 2018-09-01 |
| Preparation and Characterization of 2nd Generation HIV-1 Maturation Inhibitor Dru · topic NIAID | DFH Pharma, Inc · Maryland | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $186.4K | 2013 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.